Washington (SmartAboutHealth) - A new report released by the U.S. Centers for Disease Control and Prevention (CDC) has revealed that the rate at which teens in the U.S. are getting vaccinations against diseases is on the rise.

The CDC report aimed to see the progress being made in regards to how many teenagers in the U.S. are getting the recommended vaccinations against common diseases. Continue Reading

Washington (SmartAboutHealth) - Eli Lilly is closer than ever to getting expanded approval from the U.S. Food and Drug Administration (FDA) to market Cymbalta for chonic pain.

An advisory panel to the FDA has recommended that Eli Lilly receive approval to market Cymbalta for the treatment of chronic pain such as back problems and other ailments. Continue Reading

Washington (SmartAboutHealth) - The U.S. Food and Drug Administration (FDA) is not pleased with the pharmaceutical company Novartis to say the least. They have sent a letter to the company accusing them of violations in how they used Facebook to mislead consumers.

Social media is becoming a way that companies from all industries can advertise and target people that may fit their particular demographic. Continue Reading

Boston (SmartAboutHealth) - A new study carried out by researchers from around the world has found that there are genes in our body that actually regular our cholesterol levels.

The study was led by Dr. Dekar Kathiresan from the Harvard Medical School, and looked at the genes of roughly 100,000 people for the purpose of conducting enough data for their research. Continue Reading

Boston (SmartAboutHealth) - A new study has killed the theory that epilepsy drugs greatly increase the risk of suicide in those who take them.

Epilepsy drugs were put under the spotlight a few years ago when the U.S. Food and Drug Administration (FDA) stated that there was an increased risk of suicide in patients who used epilepsy drugs. Continue Reading

Washington (SmartAboutHealth) - A team of international scientists have managed to uncover what they believe are the origins of heart disease, high cholesterol, artery disease, etc. in the form of 95 different gene variants.

A team of roughly 200 scientists conducted this massive study that was led by Sekar Kathiresan from the Massachusetts General Hospital in Boston, MA. Continue Reading

Washington (SmartAboutHealth) - It appears that we are getting a jump start to the upcoming influenza or flu season as vaccine makers have already begun shipping flu vaccines to the U.S.

Pharmaceutical giants Sanofi Aventis as well as GlaxoSmithKline have already begun to ship flu vaccines to the U.S. in very large quantities. Continue Reading

Boston (SmartAboutHealth) - There is a great deal of support growing for a complete reform of the Toxic Substances Control Act, that would alter the way we regulate the use of chemicals that are consumed by humans as well as animals.

The House Energy and Commerce Subcommittee kicked off their first hearing to attempt to reform this particular act. Continue Reading

Boston (SmartAboutHealth) - The U.S. Food and Drug Administration (FDA) has made history as they have approved the kick-off of the world’s first embryonic stem cell trial that will include humans.

This is a huge step forward for the development of embryonic stem cells as the involvement of humans in trials has been something which has been a huge stepping stone for the groundbreaking medical treatment. Continue Reading

Boston (SmartAboutHealth) - An advisory panel to the U.S. Food and Drug Administration (FDA) has shot down a plan known as REMS which aimed to reduce the abuse of painkiller drugs that contain opioids.

REMS, or risk evaluation and mitigation strategies, aimed to try and help reduce the level of misuse and abuse of these types of drugs. Continue Reading